Peter J Barris - Net Worth and Insider Trading

Peter J Barris Net Worth

The estimated net worth of Peter J Barris is at least $2.5 Billion dollars as of 2024-05-10. Peter J Barris is the 10% Owner of Tesaro Inc and owns about 10,422,179 shares of Tesaro Inc (TSRO) stock worth over $781 Million. Peter J Barris is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,610,551 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Peter J Barris is also the 10% Owner of Supernus Pharmaceuticals Inc and owns about 7,716,055 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $231 Million. Besides these, Peter J Barris also holds Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Ardelyx Inc (ARDX) , Mirum Pharmaceuticals Inc (MIRM) , Adaptimmune Therapeutics PLC (ADAP) , Echo Global Logistics Inc (ECHO) , Boingo Wireless Inc (WIFI) , Amicus Therapeutics Inc (FOLD) , AVEO Pharmaceuticals Inc (AVEO) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , Senseonics Holdings Inc (SENS) , Millennial Media Inc (MM) , InnerWorkings Inc (INWK) , Trevi Therapeutics Inc (TRVI) , Epizyme Inc (EPZM) , Tableau Software Inc (DATA) , Surface Oncology Inc (SURF) , GlycoMimetics Inc (GLYC) , Regulus Therapeutics Inc (RGLS) , Groupon Inc (GRPN) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Genocea Biosciences Inc (GNCAQ) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) . Details can be seen in Peter J Barris's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter J Barris has not made any transactions after 2019-12-26 and currently still holds the listed stock(s).

Transaction Summary of Peter J Barris

Peter J Barris Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter J Barris owns 86 companies in total, including Sprout Social Inc (SPT) , Groupon Inc (GRPN) , and Regulus Therapeutics Inc (RGLS) among others .

Click here to see the complete history of Peter J Barris’s form 4 insider trades.

Insider Ownership Summary of Peter J Barris

Ticker	Comapny	Transaction Date	Type of Owner
SPT	Sprout Social Inc	2019-12-12	director & 10 percent owner
GRPN	Groupon Inc	2019-12-26	director & 10 percent owner
RGLS	Regulus Therapeutics Inc	2019-05-07	10 percent owner
		2016-07-18	10 percent owner
		2019-11-26	10 percent owner
		2019-11-06	10 percent owner
		2019-10-30	10 percent owner
		2019-09-12	10 percent owner
		2019-07-22	10 percent owner
		2019-06-24	10 percent owner
		2019-06-07	10 percent owner
		2019-05-09	10 percent owner
		2019-04-08	10 percent owner
		2017-07-03	10 percent owner
		2019-01-22	10 percent owner
		2018-12-14	10 percent owner
		2018-12-07	10 percent owner
		2018-10-17	10 percent owner
		2018-10-17	10 percent owner
		2018-10-04	10 percent owner
		2018-09-07	10 percent owner
		2018-07-30	10 percent owner
		2018-07-24	10 percent owner
		2018-05-10	10 percent owner
		2018-05-01	10 percent owner
		2018-04-23	10 percent owner
		2018-03-27	10 percent owner
		2018-03-09	10 percent owner
		2018-02-26	10 percent owner
		2018-02-26	10 percent owner
		2017-11-27	10 percent owner
		2015-09-30	10 percent owner
		2018-01-01	10 percent owner
		2017-12-08	10 percent owner
		2017-11-20	10 percent owner
		2017-11-06	10 percent owner
		2017-10-10	10 percent owner
		2015-01-26	10 percent owner
		2016-12-19	10 percent owner
		2016-10-11	10 percent owner
		2016-09-21	10 percent owner
		2016-07-29	10 percent owner
		2016-06-14	10 percent owner
		2016-02-03	10 percent owner
		2016-01-12	10 percent owner
		2015-06-17	10 percent owner
		2015-10-14	10 percent owner
		2015-07-01	10 percent owner
		2015-03-11	10 percent owner
		2015-01-22	10 percent owner
		2014-12-19	10 percent owner
		2014-01-30	10 percent owner
		2014-12-02	10 percent owner
		2014-11-25	10 percent owner
		2014-10-08	10 percent owner
		2014-08-27	10 percent owner
		2014-08-06	10 percent owner
		2014-04-02	10 percent owner
		2013-05-22	10 percent owner
		2013-12-05	10 percent owner
		2013-10-29	10 percent owner
		2011-11-21	10 percent owner
		2012-10-11	10 percent owner
		2012-10-29	10 percent owner
		2006-05-23	director & 10 percent owner
		2012-05-30	director
		2012-03-07	10 percent owner
		2012-03-05	director & 10 percent owner
		2011-11-16	director
		2011-08-08	10 percent owner
		2011-03-10	10 percent owner
		2010-08-30	10 percent owner
		2010-06-23	10 percent owner
		2009-05-08	10 percent owner
		2006-05-09	10 percent owner
		2007-08-14	10 percent owner
		2004-02-20	10 percent owner
		2009-04-03	10 percent owner
		2016-02-10	10 percent owner
		2018-12-07	10 percent owner
		2023-07-20	director
		2021-10-28	director
		2022-08-03	director
		2016-02-10	10 percent owner
		2018-01-19	10 percent owner
		2023-07-20	director

Peter J Barris Latest Holdings Summary

Peter J Barris currently owns a total of 34 stocks. Among these stocks, Peter J Barris owns 10,422,179 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $781 Million and a weighting of 31.43%. Peter J Barris owns 13,610,551 shares of iShares Indl/Office Real Estate Capped (FNIO) as of April 30, 2012, with a value of $434 Million and a weighting of 17.46%. Peter J Barris also owns 7,716,055 shares of Supernus Pharmaceuticals Inc (SUPN) as of June 17, 2015, with a value of $231 Million and a weighting of 9.31%. The other 31 stocks Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Ardelyx Inc (ARDX) , Mirum Pharmaceuticals Inc (MIRM) , Adaptimmune Therapeutics PLC (ADAP) , Echo Global Logistics Inc (ECHO) , Boingo Wireless Inc (WIFI) , Amicus Therapeutics Inc (FOLD) , AVEO Pharmaceuticals Inc (AVEO) , Liquidia Corp (LQDA) , Mersana Therapeutics Inc (MRSN) , Senseonics Holdings Inc (SENS) , Millennial Media Inc (MM) , InnerWorkings Inc (INWK) , Trevi Therapeutics Inc (TRVI) , Epizyme Inc (EPZM) , Tableau Software Inc (DATA) , Surface Oncology Inc (SURF) , GlycoMimetics Inc (GLYC) , Regulus Therapeutics Inc (RGLS) , Groupon Inc (GRPN) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Genocea Biosciences Inc (GNCAQ) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Appian Corp (APPN) have a combined weighting of 41.81% among all his current holdings.

Latest Holdings of Peter J Barris

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
TSRO	Tesaro Inc	2018-03-06	10,422,179	74.96	781,246,538
FNIO	iShares Indl/Office Real Estate Capped	2012-04-30	13,610,551	31.89	434,040,471
SUPN	Supernus Pharmaceuticals Inc	2015-06-17	7,716,055	29.99	231,404,489
RYTM	Rhythm Pharmaceuticals Inc	2017-10-10	4,909,956	38.46	188,836,908
RARX	Ra Pharmaceuticals Inc	2016-10-31	3,490,073	47.99	167,488,603
ARDX	Ardelyx Inc	2016-07-18	14,084,162	8.07	113,659,187
MIRM	Mirum Pharmaceuticals Inc	2019-07-22	4,186,243	25.88	108,339,969
ADAP	Adaptimmune Therapeutics PLC	2018-09-07	94,978,668	1.13	107,325,895
ECHO	Echo Global Logistics Inc	2012-03-05	1,420,901	48.24	68,544,264
WIFI	Boingo Wireless Inc	2013-12-11	4,469,108	13.99	62,522,821
FOLD	Amicus Therapeutics Inc	2012-03-07	5,650,340	9.47	53,508,720
AVEO	AVEO Pharmaceuticals Inc	2019-04-08	2,524,387	15.00	37,865,805
LQDA	Liquidia Corp	2018-07-30	2,484,870	12.48	31,011,178
MRSN	Mersana Therapeutics Inc	2017-07-03	8,140,138	2.47	20,065,440
SENS	Senseonics Holdings Inc	2017-12-08	30,936,643	0.48	14,886,713
MM	Millennial Media Inc	2012-10-29	8,196,614	1.75	14,344,075
INWK	InnerWorkings Inc	2012-05-30	4,566,835	2.99	13,654,837
TRVI	Trevi Therapeutics Inc	2019-05-09	4,438,562	2.92	12,960,601
EPZM	Epizyme Inc	2016-01-12	6,261,599	1.47	9,204,551
DATA	Tableau Software Inc	2014-08-25	40,077	169.53	6,794,254
SURF	Surface Oncology Inc	2018-04-23	3,312,877	1.07	3,544,778
GLYC	GlycoMimetics Inc	2018-05-10	9,089,041	0.30	2,708,534
RGLS	Regulus Therapeutics Inc	2019-05-07	205,245	2.23	457,696
GRPN	Groupon Inc	2019-12-26	42,476	10.50	445,998
CBIO	Catalyst Biosciences Inc	2013-12-05	43,462	7.67	333,332
DERM	Dermira Inc	2014-10-02	17,241	18.75	323,269
ILIU	Interleukin Genetics Inc	2016-07-29	55,418,811	0.00	249,385
AKAOQ	Achaogen Inc	2016-12-19	5,215,128	0.03	130,378
CLVSQ	Clovis Oncology Inc	2011-11-21	3,419,671	0.02	51,295
TCON	TRACON Pharmaceuticals Inc	2018-03-27	17,330	1.83	31,714
GNCAQ	Genocea Biosciences Inc	2019-06-24	7,225,676	0.00	723
NOVCQ	Novation Companies Inc	2006-05-15	1,225,179	0.00	123
ABIO	ARCA biopharma Inc	2018-02-26	0	3.37	0
APPN	Appian Corp	2017-11-27	0	31.66	0

Holding Weightings of Peter J Barris

Peter J Barris Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost Peter J Barris around $8 Million.

According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 16,101 shares on April 30, 2012, which brought Peter J Barris around $427,160.

According to the SEC Form 4 filings, Peter J Barris has made a total of 0 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 111,881 shares on June 17, 2015, which brought Peter J Barris around $2 Million.

More details on Peter J Barris's insider transactions can be found in the Insider Trading History of Peter J Barris table.

Insider Trading History of Peter J Barris

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter J Barris Trading Performance

GuruFocus tracks the stock performance after each of Peter J Barris's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter J Barris is 8.04%. GuruFocus also compares Peter J Barris's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter J Barris within 3 months outperforms 25 times out of 48 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter J Barris's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter J Barris

Average Return

Average return per transaction

Outperforming Transactions

12 out of 47 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	6.76
Relative Return to S&P 500(%)	6.17

Peter J Barris Ownership Network

Ownership Network List of Peter J Barris

No Data

Ownership Network Relation of Peter J Barris

Peter J Barris Owned Company Details

What does Sprout Social Inc do?

Who are the key executives at Sprout Social Inc?

Peter J Barris is the director & 10 percent owner of Sprout Social Inc. Other key executives at Sprout Social Inc include director & 10 percent owner & Chairman and CEO Justyn Russell Howard , CFO and Treasurer Preto Joseph Del , and President Ryan Paul Barretto .

Sprout Social Inc (SPT) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Sprout Social Inc (SPT). Other recent insider transactions involving Sprout Social Inc (SPT) include a net sale of 40,336 shares made by Preto Joseph Del , a net sale of 435,000 shares made by Justyn Russell Howard , and a net sale of 276,051 shares made by Rankin Aaron Edward Frederick .

In summary, during the past 3 months, insiders sold 201,940 shares of Sprout Social Inc (SPT) in total and bought 0 shares, with a net sale of 201,940 shares. During the past 18 months, 962,700 shares of Sprout Social Inc (SPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 962,700 shares.

Sprout Social Inc (SPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sprout Social Inc Insider Transactions

No Available Data

What does Groupon Inc do?

Who are the key executives at Groupon Inc?

Peter J Barris is the director & 10 percent owner of Groupon Inc. Other key executives at Groupon Inc include other: See Footnote 1 and Remarks Dusan Senkypl , Interim CAO Kyle Netzly , and Chief Financial Officer Jiri Ponrt .

Groupon Inc (GRPN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Groupon Inc (GRPN). Other recent insider transactions involving Groupon Inc (GRPN) include a net sale of 0 shares made by Jan Barta , and a net purchase of 323,344 shares made by Dusan Senkypl .

In summary, during the past 3 months, insiders sold 0 shares of Groupon Inc (GRPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,716,966 shares of Groupon Inc (GRPN) were sold and 7,040,310 shares were bought by its insiders, resulting in a net purchase of 323,344 shares.

Groupon Inc (GRPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Groupon Inc Insider Transactions

No Available Data

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Peter J Barris is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and Chief Financial Officer Crispina Calsada .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net sale of 5,468 shares made by Christopher Ray Aker .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regulus Therapeutics Inc Insider Transactions

No Available Data

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

Peter J Barris is the 10 percent owner of Ardelyx Inc. Other key executives at Ardelyx Inc include See Remarks Robert Ora Felsch , See Remarks Elizabeth A Grammer , and Chief Medical Officer Laura A Williams .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Ardelyx Inc (ARDX). Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 129,101 shares made by David P. Rosenbaum , a net sale of 480,918 shares made by Elizabeth A Grammer , and a net sale of 115,747 shares made by Michael Raab .

In summary, during the past 3 months, insiders sold 766,409 shares of Ardelyx Inc (ARDX) in total and bought 0 shares, with a net sale of 766,409 shares. During the past 18 months, 1,369,573 shares of Ardelyx Inc (ARDX) were sold and 567,000 shares were bought by its insiders, resulting in a net sale of 802,573 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ardelyx Inc Insider Transactions

No Available Data

What does Proteostasis Therapeutics Inc do?

Who are the key executives at Proteostasis Therapeutics Inc?

Peter J Barris is the 10 percent owner of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .

Proteostasis Therapeutics Inc (PTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Proteostasis Therapeutics Inc Insider Transactions

No Available Data

What does Galera Therapeutics Inc do?

Who are the key executives at Galera Therapeutics Inc?

Peter J Barris is the 10 percent owner of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include Chief Commercial Officer Mark Bachleda , Chief Financial Officer Chris Degnan , and director & President and CEO Mel Sorensen .

Galera Therapeutics Inc (GRTX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , a net purchase of 100,000 shares made by Mel Sorensen , and a net purchase of 11,000 shares made by Mark Bachleda .

In summary, during the past 3 months, insiders sold 0 shares of Galera Therapeutics Inc (GRTX) in total and bought 2,780,407 shares, with a net purchase of 2,780,407 shares. During the past 18 months, 0 shares of Galera Therapeutics Inc (GRTX) were sold and 3,833,809 shares were bought by its insiders, resulting in a net purchase of 3,833,809 shares.

Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Galera Therapeutics Inc Insider Transactions

No Available Data

What does Oyster Point Pharma Inc do?

Who are the key executives at Oyster Point Pharma Inc?

Peter J Barris is the 10 percent owner of Oyster Point Pharma Inc. Other key executives at Oyster Point Pharma Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & 10 percent owner Link William J Phd , and Chief Commercial Officer John Snisarenko .

Oyster Point Pharma Inc (OYST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oyster Point Pharma Inc Insider Transactions

No Available Data

What does Cloudflare Inc do?

Who are the key executives at Cloudflare Inc?

Peter J Barris is the 10 percent owner of Cloudflare Inc. Other key executives at Cloudflare Inc include director & 10 percent owner Carl Ledbetter , director & 10 percent owner & CEO and Chair of the Board Matthew Prince , and Chief Financial Officer Thomas J Seifert .

Cloudflare Inc (NET) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Cloudflare Inc (NET). Other recent insider transactions involving Cloudflare Inc (NET) include a net sale of 802,451 shares made by Carl Ledbetter , a net sale of 893,812 shares made by Thomas J Seifert , and a net sale of 2,985,888 shares made by Matthew Prince .

In summary, during the past 3 months, insiders sold 1,692,457 shares of Cloudflare Inc (NET) in total and bought 0 shares, with a net sale of 1,692,457 shares. During the past 18 months, 6,010,768 shares of Cloudflare Inc (NET) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,010,768 shares.

Cloudflare Inc (NET)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cloudflare Inc Insider Transactions

No Available Data

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include Chief Financial Officer Eric Bjerkholt , Chief Operating Officer Peter Radovich , and SVP & Global Controller Jolanda Howe .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 10,305 shares made by Peter Radovich , a net sale of 8,137 shares made by Jolanda Howe , and a net purchase of 161,963 shares made by Patrick J Heron .

In summary, during the past 3 months, insiders sold 4,303 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 4,000 shares, with a net sale of 303 shares. During the past 18 months, 393,444 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 175,963 shares were bought by its insiders, resulting in a net sale of 217,481 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Peter J Barris is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .

Genocea Biosciences Inc (GNCAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genocea Biosciences Inc Insider Transactions

No Available Data

What does Nightstar Therapeutics PLC do?

Who are the key executives at Nightstar Therapeutics PLC?

Peter J Barris is the 10 percent owner of Nightstar Therapeutics PLC. Other key executives at Nightstar Therapeutics PLC include 10 percent owner Scott D Sandell , director & 10 percent owner David M Mott , and 10 percent owner Joshua Makower .

Nightstar Therapeutics PLC (NITE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nightstar Therapeutics PLC (NITE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nightstar Therapeutics PLC (NITE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nightstar Therapeutics PLC (NITE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nightstar Therapeutics PLC Insider Transactions

No Available Data

What does Trevi Therapeutics Inc do?

Who are the key executives at Trevi Therapeutics Inc?

Peter J Barris is the 10 percent owner of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include Chief Financial Officer Lisa Delfini , Chief Commercial Officer Farrell Simon , and Chief Medical Officer David J Clark .

Trevi Therapeutics Inc (TRVI) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 14,243 shares made by Lisa Delfini ,

In summary, during the past 3 months, insiders sold 0 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,243 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,243 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevi Therapeutics Inc Insider Transactions

No Available Data

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

What does Mersana Therapeutics Inc do?

Who are the key executives at Mersana Therapeutics Inc?

Peter J Barris is the 10 percent owner of Mersana Therapeutics Inc. Other key executives at Mersana Therapeutics Inc include director & President and CEO Anna Protopapas , SVP & Chief Development Officer Mohan Bala , and Chief Manufacturing Officer Tushar Misra .

Mersana Therapeutics Inc (MRSN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Mersana Therapeutics Inc (MRSN). Other recent insider transactions involving Mersana Therapeutics Inc (MRSN) include a net sale of 9,107 shares made by Alejandra Carvajal , a net sale of 5,723 shares made by Tushar Misra , and a net sale of 46,745 shares made by Anna Protopapas .

In summary, during the past 3 months, insiders sold 0 shares of Mersana Therapeutics Inc (MRSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,354 shares of Mersana Therapeutics Inc (MRSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114,354 shares.

Mersana Therapeutics Inc (MRSN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mersana Therapeutics Inc Insider Transactions

No Available Data

What does Tesaro Inc do?

Who are the key executives at Tesaro Inc?

Peter J Barris is the 10 percent owner of Tesaro Inc. Other key executives at Tesaro Inc include director & President & COO Mary Lynne Hedley , SVP & Chief Medical Officer Huber Martin H. Jr. , and director & Chief Executive Officer Moulder Leon O Jr .

Tesaro Inc (TSRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tesaro Inc Insider Transactions

No Available Data

What does Ra Pharmaceuticals Inc do?

Who are the key executives at Ra Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & President and CEO Douglas A Treco , and 10 percent owner Scott D Sandell .

Ra Pharmaceuticals Inc (RARX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ra Pharmaceuticals Inc Insider Transactions

No Available Data

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Peter J Barris is the 10 percent owner of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include General Counsel and Secretary Tamara L Joseph , Chief Financial Officer Arcudi Iii Louis J , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millendo Therapeutics Inc Insider Transactions

No Available Data

What does PhaseBio Pharmaceuticals Inc do?

Who are the key executives at PhaseBio Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of PhaseBio Pharmaceuticals Inc. Other key executives at PhaseBio Pharmaceuticals Inc include 10 percent owner New Enterprise Associates 13 Lp , VP & Human Resources Glen Burkhardt , and Chief Commercial Officer Jonathan Birchall .

PhaseBio Pharmaceuticals Inc (PHASQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseBio Pharmaceuticals Inc (PHASQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

PhaseBio Pharmaceuticals Inc Insider Transactions

No Available Data

What does Marker Therapeutics Inc do?

Who are the key executives at Marker Therapeutics Inc?

Peter J Barris is the 10 percent owner of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include Interim CFO Eliot M Lurier , 10 percent owner Scott D Sandell , and 10 percent owner Joshua Makower .

Marker Therapeutics Inc (MRKR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marker Therapeutics Inc Insider Transactions

No Available Data

What does Elastic NV do?

Who are the key executives at Elastic NV?

Peter J Barris is the 10 percent owner of Elastic NV. Other key executives at Elastic NV include Chief Legal Officer Carolyn Herzog , director & 10 percent owner Steven Schuurman , and director & 10 percent owner & CEO and Chairman Shay Banon .

Elastic NV (ESTC) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Elastic NV (ESTC). Other recent insider transactions involving Elastic NV (ESTC) include a net sale of 36,700 shares made by Carolyn Herzog , a net sale of 695,337 shares made by Shay Banon , and a net sale of 67,287 shares made by Ashutosh Kulkarni .

In summary, during the past 3 months, insiders sold 1,144,969 shares of Elastic NV (ESTC) in total and bought 0 shares, with a net sale of 1,144,969 shares. During the past 18 months, 1,772,596 shares of Elastic NV (ESTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,772,596 shares.

Elastic NV (ESTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elastic NV Insider Transactions

No Available Data

What does Adaptimmune Therapeutics PLC do?

Who are the key executives at Adaptimmune Therapeutics PLC?

Peter J Barris is the 10 percent owner of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Medical Officer Elliot Norry , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .

Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 115,184 shares made by Adrian Rawcliffe , a net sale of 48,376 shares made by John Lunger , and a net sale of 46,074 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315,048 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,048 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adaptimmune Therapeutics PLC Insider Transactions

No Available Data

What does Liquidia Corp do?

Who are the key executives at Liquidia Corp?

Peter J Barris is the 10 percent owner of Liquidia Corp. Other key executives at Liquidia Corp include Chief Medical Officer Rajeev Saggar , SVP & Commercial Scott Moomaw , and Chief Financial Officer Michael Kaseta .

Liquidia Corp (LQDA) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Liquidia Corp (LQDA). Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 14,311 shares made by Scott Moomaw , a net sale of 7,350 shares made by Jason Adair , and a net sale of 25,591 shares made by Rajeev Saggar .

In summary, during the past 3 months, insiders sold 88,202 shares of Liquidia Corp (LQDA) in total and bought 0 shares, with a net sale of 88,202 shares. During the past 18 months, 113,842 shares of Liquidia Corp (LQDA) were sold and 1,536,313 shares were bought by its insiders, resulting in a net purchase of 1,422,471 shares.

Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Liquidia Corp Insider Transactions

No Available Data

What does Bloom Energy Corp do?

Who are the key executives at Bloom Energy Corp?

Peter J Barris is the 10 percent owner of Bloom Energy Corp. Other key executives at Bloom Energy Corp include EVP & GC & Secretary Shawn Marie Soderberg , director & Chairman & CEO Kr Sridhar , and EVP & Sales - Americas Guillermo Brooks .

Bloom Energy Corp (BE) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Bloom Energy Corp (BE). Other recent insider transactions involving Bloom Energy Corp (BE) include a net sale of 102,815 shares made by Shawn Marie Soderberg , a net sale of 78,213 shares made by Sharelynn Faye Moore , and a net sale of 356,556 shares made by Kr Sridhar .

In summary, during the past 3 months, insiders sold 74,989 shares of Bloom Energy Corp (BE) in total and bought 0 shares, with a net sale of 74,989 shares. During the past 18 months, 670,490 shares of Bloom Energy Corp (BE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 670,490 shares.

Bloom Energy Corp (BE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bloom Energy Corp Insider Transactions

No Available Data

What does GlycoMimetics Inc do?

Who are the key executives at GlycoMimetics Inc?

Peter J Barris is the 10 percent owner of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include Chief Medical Officer Edwin Rock , CFO Brian M. Hahn , and SVP & Chief Commercial Officer Bruce S Johnson .

GlycoMimetics Inc (GLYC) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net purchase of 2,026,717 shares made by Invus Public Equities, L.p. , a net sale of 4,121,511 shares made by Scott D Sandell , and a net purchase of 375,403 shares made by Edwin Rock .

In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,125,211 shares of GlycoMimetics Inc (GLYC) were sold and 2,581,565 shares were bought by its insiders, resulting in a net sale of 1,543,646 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

GlycoMimetics Inc Insider Transactions

No Available Data

What does MuleSoft Inc do?

Who are the key executives at MuleSoft Inc?

Peter J Barris is the 10 percent owner of MuleSoft Inc. Other key executives at MuleSoft Inc include 10 percent owner Scott D Sandell , 10 percent owner Nea 14 Gp, Ltd , and 10 percent owner Nea Partners 14, L.p. .

MuleSoft Inc (MULE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MuleSoft Inc (MULE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MuleSoft Inc (MULE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MuleSoft Inc (MULE)'s detailed insider trading history can be found in Insider Trading Tracker table.

MuleSoft Inc Insider Transactions

No Available Data

What does Surface Oncology Inc do?

Who are the key executives at Surface Oncology Inc?

Peter J Barris is the 10 percent owner of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .

Surface Oncology Inc (SURF) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Surface Oncology Inc (SURF). Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 16,713 shares made by Robert W. Ross , a net sale of 9,434 shares made by Jessica Fees , and a net sale of 7,042 shares made by Alison Oneill .

In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.

Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Surface Oncology Inc Insider Transactions

No Available Data

What does TRACON Pharmaceuticals Inc do?

Who are the key executives at TRACON Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .

TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net purchase of 99,699 shares made by Charles Theuer , a net sale of 4,423,539 shares made by Opaleye Management Inc. , and a net purchase of 3,500 shares made by Scott B. Brown .

In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,283 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 22,260 shares were bought by its insiders, resulting in a net sale of 216,023 shares.

TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.

TRACON Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cascadian Therapeutics Inc do?

Who are the key executives at Cascadian Therapeutics Inc?

Peter J Barris is the 10 percent owner of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea Partners 15, L.p. , 10 percent owner Jon Sakoda , and 10 percent owner Florence Anthony A. Jr. .

Cascadian Therapeutics Inc (CASC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cascadian Therapeutics Inc Insider Transactions

No Available Data

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Peter J Barris is the 10 percent owner of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

What does Tintri Inc do?

Who are the key executives at Tintri Inc?

Peter J Barris is the 10 percent owner of Tintri Inc. Other key executives at Tintri Inc include director & Chairman & CEO Kenneth Klein , 10 percent owner Insight Venture Associates Viii, Ltd. , and 10 percent owner Insight Venture Associates Viii, L.p. .

Tintri Inc (TNTRQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tintri Inc (TNTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tintri Inc (TNTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tintri Inc (TNTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tintri Inc Insider Transactions

No Available Data

What does Appian Corp do?

Who are the key executives at Appian Corp?

Peter J Barris is the 10 percent owner of Appian Corp. Other key executives at Appian Corp include 10 percent owner Abdiel Qualified Master Fund Lp , Chief Revenue Officer Christopher M Jones , and Chief Accounting Officer Mark Matheos .

Appian Corp (APPN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Appian Corp (APPN). Other recent insider transactions involving Appian Corp (APPN) include a net sale of 2,597,214 shares made by Abdiel Qualified Master Fund Lp , a net sale of 30,000 shares made by Christopher Winters , and a net sale of 13,068 shares made by Mark Matheos .

In summary, during the past 3 months, insiders sold 400,000 shares of Appian Corp (APPN) in total and bought 0 shares, with a net sale of 400,000 shares. During the past 18 months, 4,279,218 shares of Appian Corp (APPN) were sold and 1,634,436 shares were bought by its insiders, resulting in a net sale of 2,644,782 shares.

Appian Corp (APPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Appian Corp Insider Transactions

No Available Data

What does Synlogic Inc do?

Who are the key executives at Synlogic Inc?

Peter J Barris is the 10 percent owner of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 6,810 shares made by Antoine Awad , a net sale of 19,042 shares made by Aoife Brennan , and a net sale of 2,553 shares made by Michael Vangsted Jensen .

In summary, during the past 3 months, insiders sold 560 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 560 shares. During the past 18 months, 28,593 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 28,593 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synlogic Inc Insider Transactions

No Available Data

What does Strongbridge Biopharma PLC do?

Who are the key executives at Strongbridge Biopharma PLC?

Peter J Barris is the 10 percent owner of Strongbridge Biopharma PLC. Other key executives at Strongbridge Biopharma PLC include 10 percent owner Cdk Associates, L.l.c. , 10 percent owner Caxton Corp , and 10 percent owner Bruce Kovner .

Strongbridge Biopharma PLC (SBBP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Strongbridge Biopharma PLC Insider Transactions

No Available Data

What does Senseonics Holdings Inc do?

Who are the key executives at Senseonics Holdings Inc?

Peter J Barris is the 10 percent owner of Senseonics Holdings Inc. Other key executives at Senseonics Holdings Inc include Chief Financial Officer Frederick T. Sullivan , VP Operations & Qual & Reg Mukul Jain , and VP Global Sales & Marketing Mirasol Panlilio .

Senseonics Holdings Inc (SENS) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Senseonics Holdings Inc (SENS). Other recent insider transactions involving Senseonics Holdings Inc (SENS) include a net purchase of 300,000 shares made by Douglas A Roeder , and a net sale of 30,889 shares made by Sharon Larkin .

In summary, during the past 3 months, insiders sold 0 shares of Senseonics Holdings Inc (SENS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 30,889 shares of Senseonics Holdings Inc (SENS) were sold and 300,000 shares were bought by its insiders, resulting in a net purchase of 269,111 shares.

Senseonics Holdings Inc (SENS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senseonics Holdings Inc Insider Transactions

No Available Data

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include Chief Scientific Officer Arthur Taveras , Chief Operating Officer Mary Dibiase , and See Remarks Adam S. Mostafa .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 401,923 shares made by Paula Ragan , a net sale of 113,683 shares made by Mary Dibiase , and a net sale of 401,921 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 185,708 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 185,708 shares. During the past 18 months, 1,158,291 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,133,291 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

What does Care.com Inc do?

Who are the key executives at Care.com Inc?

Peter J Barris is the 10 percent owner of Care.com Inc. Other key executives at Care.com Inc include 10 percent owner Ac/interactivecorp , 10 percent owner Capitalg Gp Llc , and 10 percent owner Alphabet Inc. .

Care.com Inc (CRCM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Care.com Inc (CRCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Care.com Inc (CRCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Care.com Inc (CRCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Care.com Inc Insider Transactions

No Available Data

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Corporate Controller & CAO Christopher Paul German , Chief Technical Officer Joseph Shulman , and EVP & Head of North America Jennifer Chien .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 81,925 shares made by Jennifer Chien , a net sale of 154,303 shares made by Joseph Shulman , and a net sale of 72,562 shares made by Hunter C Smith .

In summary, during the past 3 months, insiders sold 243,187 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 243,187 shares. During the past 18 months, 404,456 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 404,456 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Peter J Barris is the 10 percent owner of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include director & Chief Executive Officer Steven Lo , Chief Financial Officer Christine Matthews , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zosano Pharma Corp Insider Transactions

No Available Data

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Peter J Barris is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does Xtera Communications Inc do?

Who are the key executives at Xtera Communications Inc?

Peter J Barris is the 10 percent owner of Xtera Communications Inc. Other key executives at Xtera Communications Inc include 10 percent owner Arch Venture Partners Vi Llc , 10 percent owner Keith Crandell , and 10 percent owner Robert Nelsen .

Xtera Communications Inc (XCOMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xtera Communications Inc (XCOMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xtera Communications Inc (XCOMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xtera Communications Inc (XCOMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xtera Communications Inc Insider Transactions

No Available Data

What does Sorrento Tech Inc do?

Who are the key executives at Sorrento Tech Inc?

Peter J Barris is the 10 percent owner of Sorrento Tech Inc. Other key executives at Sorrento Tech Inc include 10 percent owner Orbimed Capital Gp Iii Llc , 10 percent owner Samuel D Isaly , and 10 percent owner Orbimed Advisors Llc .

Sorrento Tech Inc (ROKA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Tech Inc (ROKA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Tech Inc (ROKA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Tech Inc (ROKA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Tech Inc Insider Transactions

No Available Data

What does Interleukin Genetics Inc do?

Who are the key executives at Interleukin Genetics Inc?

Peter J Barris is the 10 percent owner of Interleukin Genetics Inc. Other key executives at Interleukin Genetics Inc include 10 percent owner New Enterprise Associates 14, L.p. , 10 percent owner Growth Equity Opportunities Fund III, LLC , and Interim CFO Stephen J. Dipalma .

Interleukin Genetics Inc (ILIU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interleukin Genetics Inc (ILIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interleukin Genetics Inc (ILIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interleukin Genetics Inc (ILIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Interleukin Genetics Inc Insider Transactions

No Available Data

What does Opower Inc do?

Who are the key executives at Opower Inc?

Peter J Barris is the 10 percent owner of Opower Inc. Other key executives at Opower Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Scott D Sandell , and 10 percent owner M James Barrett .

Opower Inc (OPWR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Opower Inc (OPWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Opower Inc (OPWR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Opower Inc (OPWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Opower Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

Peter J Barris is the 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Krishna Kittu Kolluri , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Peter J Barris is the 10 percent owner of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epizyme Inc Insider Transactions

No Available Data

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , Sr. V.P. & Regulatory Affairs Tami Tillotson Martin , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 115,305 shares made by Padmanabh P. Bhatt , a net sale of 76,390 shares made by Jack A. Khattar , and a net sale of 21,235 shares made by Tami Tillotson Martin .

In summary, during the past 3 months, insiders sold 98,505 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 98,505 shares. During the past 18 months, 230,413 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 230,413 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Peter J Barris is the 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 6,083 shares made by Garry Arthur Neil .

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avalo Therapeutics Inc Insider Transactions

No Available Data

What does Vitae Pharmaceuticals Inc do?

Who are the key executives at Vitae Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Vitae Pharmaceuticals Inc. Other key executives at Vitae Pharmaceuticals Inc include Chief Financial Officer Richard Steven Morris , General Counsel Scott Applebaum , and Chief Medical Officer Carole Sable .

Vitae Pharmaceuticals Inc (VTAE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vitae Pharmaceuticals Inc (VTAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vitae Pharmaceuticals Inc (VTAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vitae Pharmaceuticals Inc (VTAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vitae Pharmaceuticals Inc Insider Transactions

No Available Data

What does Champions Oncology Inc do?

Who are the key executives at Champions Oncology Inc?

Peter J Barris is the 10 percent owner of Champions Oncology Inc. Other key executives at Champions Oncology Inc include director & President Ronnie Morris , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Roger H Lee .

Champions Oncology Inc (CSBR) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Champions Oncology Inc (CSBR). Other recent insider transactions involving Champions Oncology Inc (CSBR) include a net purchase of 75,504 shares made by Daniel Newman Mendelson , and a net purchase of 12,382 shares made by Ronnie Morris .

In summary, during the past 3 months, insiders sold 0 shares of Champions Oncology Inc (CSBR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Champions Oncology Inc (CSBR) were sold and 87,886 shares were bought by its insiders, resulting in a net purchase of 87,886 shares.

Champions Oncology Inc (CSBR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Champions Oncology Inc Insider Transactions

No Available Data

What does Box Inc do?

Who are the key executives at Box Inc?

Peter J Barris is the 10 percent owner of Box Inc. Other key executives at Box Inc include director & 10 percent owner & Chief Financial Officer Dylan C Smith , director & 10 percent owner & President & COO Daniel J Levin , and director & 10 percent owner & Chief Executive Officer Aaron Levie .

Box Inc (BOX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Box Inc (BOX). Other recent insider transactions involving Box Inc (BOX) include a net sale of 221,000 shares made by Dylan C Smith , a net sale of 550,000 shares made by Daniel J Levin , and a net sale of 25,750 shares made by Eli Berkovitch .

In summary, during the past 3 months, insiders sold 190,660 shares of Box Inc (BOX) in total and bought 0 shares, with a net sale of 190,660 shares. During the past 18 months, 866,049 shares of Box Inc (BOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 866,049 shares.

Box Inc (BOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Box Inc Insider Transactions

No Available Data

What does Boingo Wireless Inc do?

Who are the key executives at Boingo Wireless Inc?

Peter J Barris is the 10 percent owner of Boingo Wireless Inc. Other key executives at Boingo Wireless Inc include Chief Technology Officer Derek Peterson , Chief Financial Officer Peter Hovenier , and Chief Marketing Officer Dawn Callahan .

Boingo Wireless Inc (WIFI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Boingo Wireless Inc (WIFI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Boingo Wireless Inc (WIFI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Boingo Wireless Inc (WIFI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Boingo Wireless Inc Insider Transactions

No Available Data

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

Peter J Barris is the 10 percent owner of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

What does Tableau Software Inc do?

Who are the key executives at Tableau Software Inc?

Peter J Barris is the 10 percent owner of Tableau Software Inc. Other key executives at Tableau Software Inc include EVP & GC & Secretary Keenan Michael Conder , EVP & Product Development Mark Thomas Nelson , and Executive VP & Sales Kelly Wright .

Tableau Software Inc (DATA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tableau Software Inc (DATA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tableau Software Inc (DATA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tableau Software Inc (DATA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tableau Software Inc Insider Transactions

No Available Data

What does Cvent Inc do?

Who are the key executives at Cvent Inc?

Peter J Barris is the 10 percent owner of Cvent Inc. Other key executives at Cvent Inc include Chief Financial Officer Cynthia A Russo , 10 percent owner Insight Venture Partners Vii, L.p. , and 10 percent owner Insight Venture Partners (delaware) Vii, L.p. .

Cvent Inc (CVT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cvent Inc (CVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cvent Inc (CVT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cvent Inc (CVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cvent Inc Insider Transactions

No Available Data

What does Dermira Inc do?

Who are the key executives at Dermira Inc?

Peter J Barris is the 10 percent owner of Dermira Inc. Other key executives at Dermira Inc include director & Chief Medical Officer Eugene A Bauer , director & CEO & Chairman of the Board Thomas G Wiggans , and CFO Andrew Guggenhime .

Dermira Inc (DERM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dermira Inc (DERM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dermira Inc (DERM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dermira Inc (DERM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dermira Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Loxo Oncology Inc do?

Who are the key executives at Loxo Oncology Inc?

Peter J Barris is the 10 percent owner of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .

Loxo Oncology Inc (LOXO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Loxo Oncology Inc Insider Transactions

No Available Data

What does Aerohive Networks Inc do?

Who are the key executives at Aerohive Networks Inc?

Peter J Barris is the 10 percent owner of Aerohive Networks Inc. Other key executives at Aerohive Networks Inc include VP & Gen. Counsel & Secretary Stephen Debenham , SVP & CFO & COO John Ritchie , and 10 percent owner Lightspeed General Partner Vii, L.p. .

Aerohive Networks Inc (HIVE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerohive Networks Inc (HIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerohive Networks Inc (HIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerohive Networks Inc (HIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerohive Networks Inc Insider Transactions

No Available Data

What does ChannelAdvisor Corp do?

Who are the key executives at ChannelAdvisor Corp?

Peter J Barris is the 10 percent owner of ChannelAdvisor Corp. Other key executives at ChannelAdvisor Corp include director & Chief Executive Officer M Scot Wingo , Chief Operating Officer Elizabeth Segovia , and President and COO David J Spitz .

ChannelAdvisor Corp (ECOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChannelAdvisor Corp (ECOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChannelAdvisor Corp (ECOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChannelAdvisor Corp (ECOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChannelAdvisor Corp Insider Transactions

No Available Data

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Peter J Barris is the 10 percent owner of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does Xoom Corp do?

Who are the key executives at Xoom Corp?

Peter J Barris is the 10 percent owner of Xoom Corp. Other key executives at Xoom Corp include 10 percent owner Capital Xi Sequoia , 10 percent owner Sequoia Technology Partners Xi , and 10 percent owner Sequoia Capital Xi Principals Fund .

Xoom Corp (XOOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xoom Corp (XOOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xoom Corp (XOOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xoom Corp (XOOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xoom Corp Insider Transactions

No Available Data

What does Clovis Oncology Inc do?

Who are the key executives at Clovis Oncology Inc?

Peter J Barris is the 10 percent owner of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .

Clovis Oncology Inc (CLVSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clovis Oncology Inc Insider Transactions

No Available Data

What does Workday Inc do?

Who are the key executives at Workday Inc?

Peter J Barris is the 10 percent owner of Workday Inc. Other key executives at Workday Inc include 10 percent owner David A Duffield , Co-President Sayan Chakraborty , and EVP & General Counsel & Secty Richard Harry Sauer .

Workday Inc (WDAY) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Workday Inc (WDAY). Other recent insider transactions involving Workday Inc (WDAY) include a net sale of 35,574 shares made by Douglas A. Robinson , a net sale of 1,219,145 shares made by David A Duffield , and a net sale of 63,009 shares made by Sayan Chakraborty .

In summary, during the past 3 months, insiders sold 566,147 shares of Workday Inc (WDAY) in total and bought 0 shares, with a net sale of 566,147 shares. During the past 18 months, 1,523,908 shares of Workday Inc (WDAY) were sold and 8,676 shares were bought by its insiders, resulting in a net sale of 1,515,232 shares.

Workday Inc (WDAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Workday Inc Insider Transactions

No Available Data

What does Millennial Media Inc do?

Who are the key executives at Millennial Media Inc?

Peter J Barris is the 10 percent owner of Millennial Media Inc. Other key executives at Millennial Media Inc include VP & Controller & Treasurer Lara Sweet , director & President Robert Lord , and 10 percent owner Verizon Communications Inc .

Millennial Media Inc (MM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millennial Media Inc (MM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millennial Media Inc (MM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millennial Media Inc (MM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millennial Media Inc Insider Transactions

No Available Data

What does Vonage Holdings Corp do?

Who are the key executives at Vonage Holdings Corp?

Peter J Barris is the director & 10 percent owner of Vonage Holdings Corp. Other key executives at Vonage Holdings Corp include SVP Corporate Development Vinod Lala , Interim Chief Legal Officer Randy K. Rutherford , and director & Chief Executive Officer Rory P Read .

Vonage Holdings Corp (VG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vonage Holdings Corp (VG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vonage Holdings Corp (VG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vonage Holdings Corp (VG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vonage Holdings Corp Insider Transactions

No Available Data

What does InnerWorkings Inc do?

Who are the key executives at InnerWorkings Inc?

Peter J Barris is the director of InnerWorkings Inc. Other key executives at InnerWorkings Inc include director & President and CEO Richard S Stoddart , Chief Accounting Officer John Bosshart , and Executive VP and CFO Donald W Pearson .

InnerWorkings Inc (INWK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InnerWorkings Inc (INWK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InnerWorkings Inc (INWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InnerWorkings Inc (INWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

InnerWorkings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Peter J Barris is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 634,200 shares made by John F Crowley , a net sale of 260,446 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .

In summary, during the past 3 months, insiders sold 115,222 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 115,222 shares. During the past 18 months, 1,232,982 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,232,982 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

Peter J Barris is the director & 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does Inteliquent Inc do?

Who are the key executives at Inteliquent Inc?

Peter J Barris is the director of Inteliquent Inc. Other key executives at Inteliquent Inc include director & President and CEO Matthew Jr Carter , Chief Financial Officer / EVP Kurt Abkemeier , and 10 percent owner C Richard Kramlich .

Inteliquent Inc (IQNT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inteliquent Inc (IQNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inteliquent Inc (IQNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inteliquent Inc (IQNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inteliquent Inc Insider Transactions

No Available Data

What does Glu Mobile Inc do?

Who are the key executives at Glu Mobile Inc?

Peter J Barris is the 10 percent owner of Glu Mobile Inc. Other key executives at Glu Mobile Inc include EVP & COO and CFO Eric R Ludwig , Senior Vice President & Revenue Becky Ann Hughes , and SVP & Business & Corp. Dev. Chris Akhavan .

Glu Mobile Inc (GLUU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Glu Mobile Inc (GLUU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Glu Mobile Inc (GLUU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Glu Mobile Inc (GLUU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glu Mobile Inc Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Peter J Barris is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Financial Engines Inc do?

Who are the key executives at Financial Engines Inc?

Peter J Barris is the 10 percent owner of Financial Engines Inc. Other key executives at Financial Engines Inc include EVP & COO & Pres FE Advisors John Bunch , EVP & CFO Craig L Foster , and other: See footnotes (1)(2)(3)(4) Warburg Pincus Llc .

Financial Engines Inc (FNGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Financial Engines Inc (FNGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Financial Engines Inc (FNGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Financial Engines Inc (FNGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Financial Engines Inc Insider Transactions

No Available Data

What does Voltari Corp do?

Who are the key executives at Voltari Corp?

Peter J Barris is the 10 percent owner of Voltari Corp. Other key executives at Voltari Corp include 10 percent owner Carl C Icahn , Chief Financial Officer Nathan Yu-gai Fong , and SVP & Gen Counsel & Corp Sec Richard Jr Leigh .

Voltari Corp (VLTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Voltari Corp (VLTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Voltari Corp (VLTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Voltari Corp (VLTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Voltari Corp Insider Transactions

No Available Data

What does W World Corp do?

Who are the key executives at W World Corp?

Peter J Barris is the 10 percent owner of W World Corp. Other key executives at W World Corp include director & 10 percent owner Anthony B Evnin , director & 10 percent owner Newhall Charles W Iii , and President and CFO Neill Sydney Colin .

W World Corp (WWHC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of W World Corp (WWHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of W World Corp (WWHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

W World Corp (WWHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

W World Corp Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Peter J Barris is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 172,206 shares made by Evan Loh , a net sale of 98,375 shares made by Michael Bigham , and a net sale of 79,527 shares made by William M. Haskel .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 442,355 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 788,500 shares were bought by its insiders, resulting in a net purchase of 346,145 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does DZS Inc do?

Who are the key executives at DZS Inc?

Peter J Barris is the 10 percent owner of DZS Inc. Other key executives at DZS Inc include Chief Customer Officer & AEMEA Gunter Reiss , Chief Financial Officer Misty Dawn Kawecki , and director & President & CEO Charles D Vogt .

DZS Inc (DZSI) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in DZS Inc (DZSI). Other recent insider transactions involving DZS Inc (DZSI) include a net sale of 1,000,000 shares made by Dasan Networks, Inc , a net purchase of 20,000 shares made by Charles D Vogt , and a net purchase of 10,000 shares made by Misty Dawn Kawecki .

In summary, during the past 3 months, insiders sold 0 shares of DZS Inc (DZSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000,000 shares of DZS Inc (DZSI) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 970,000 shares.

DZS Inc (DZSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

DZS Inc Insider Transactions

No Available Data

What does Aradigm Corp do?

Who are the key executives at Aradigm Corp?

Peter J Barris is the 10 percent owner of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner 21 April Fund Lp .

Aradigm Corp (ARDMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aradigm Corp Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Peter J Barris is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 21,403 shares made by Daniel R. Chevallard , a net sale of 4,272 shares made by Lisa Rojkjaer , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 3,405 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 3,405 shares. During the past 18 months, 25,675 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 74,325 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Peter J Barris is the 10 percent owner of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Yumanity Therapeutics Inc (YMTX). Other recent insider transactions involving Yumanity Therapeutics Inc (YMTX) include a net sale of 10,890 shares made by Richard Peters , a net sale of 3,116 shares made by Michael D Wyzga , and a net sale of 3,116 shares made by Devin Whittemore Smith .

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,098 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,098 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yumanity Therapeutics Inc Insider Transactions

No Available Data

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Peter J Barris is the 10 percent owner of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include Corporate Controller Justin Trojanowski , VP of Strategy and Finance Nicholas Maestas , and director & 10 percent owner Thomas Woiwode .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tempest Therapeutics Inc (TPST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tempest Therapeutics Inc Insider Transactions

No Available Data

What does Berkshire Grey Inc do?

Who are the key executives at Berkshire Grey Inc?

Peter J Barris is the director of Berkshire Grey Inc. Other key executives at Berkshire Grey Inc include 10 percent owner Svf Ii Bg (de) Llc , 10 percent owner Softbank Group Corp , and director & Chief Executive Officer Thomas Anderson Wagner .

Berkshire Grey Inc (BGRY) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Berkshire Grey Inc (BGRY). Other recent insider transactions involving Berkshire Grey Inc (BGRY) include a net sale of 65,567,317 shares made by Svf Ii Bg (de) Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Berkshire Grey Inc (BGRY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 65,567,317 shares of Berkshire Grey Inc (BGRY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,567,317 shares.

Berkshire Grey Inc (BGRY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Berkshire Grey Inc Insider Transactions

No Available Data

What does NextNav Inc do?

Who are the key executives at NextNav Inc?

Peter J Barris is the director of NextNav Inc. Other key executives at NextNav Inc include General Counsel Robert Lantz , Corporate Controller Sammaad Shams , and SVP & Engineering Arun Raghupathy .

NextNav Inc (NN) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in NextNav Inc (NN). Other recent insider transactions involving NextNav Inc (NN) include a net sale of 37,651 shares made by Sammaad Shams , a net sale of 87,766 shares made by David L. Knutson , and a net sale of 19,587 shares made by Robert Lantz .

In summary, during the past 3 months, insiders sold 77,148 shares of NextNav Inc (NN) in total and bought 633,000 shares, with a net purchase of 555,852 shares. During the past 18 months, 549,275 shares of NextNav Inc (NN) were sold and 933,000 shares were bought by its insiders, resulting in a net purchase of 383,725 shares.

NextNav Inc (NN)'s detailed insider trading history can be found in Insider Trading Tracker table.

NextNav Inc Insider Transactions

No Available Data

What does ZeroFox Holdings Inc do?

Who are the key executives at ZeroFox Holdings Inc?

Peter J Barris is the director of ZeroFox Holdings Inc. Other key executives at ZeroFox Holdings Inc include director & See Remarks James Christopher Foster , Chief Marketing Officer Prestridge Iii John R , and Chief Technology Officer Michael Morgan Price .

ZeroFox Holdings Inc (ZFOX) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in ZeroFox Holdings Inc (ZFOX). Other recent insider transactions involving ZeroFox Holdings Inc (ZFOX) include a net sale of 224,517 shares made by James Christopher Foster , a net sale of 59,691 shares made by Timothy S Bender , and a net sale of 54,174 shares made by Michael Morgan Price .

In summary, during the past 3 months, insiders sold 232,200 shares of ZeroFox Holdings Inc (ZFOX) in total and bought 0 shares, with a net sale of 232,200 shares. During the past 18 months, 515,540 shares of ZeroFox Holdings Inc (ZFOX) were sold and 51,000 shares were bought by its insiders, resulting in a net sale of 464,540 shares.

ZeroFox Holdings Inc (ZFOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ZeroFox Holdings Inc Insider Transactions

No Available Data

What does Kineta Inc do?

Who are the key executives at Kineta Inc?

Peter J Barris is the 10 percent owner of Kineta Inc. Other key executives at Kineta Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Kineta Inc (KA) Insider Trades Summary

Over the past 18 months, Peter J Barris made no insider transaction in Kineta Inc (KA). Other recent insider transactions involving Kineta Inc (KA) include a net purchase of 12,301 shares made by Shawn Iadonato , a net purchase of 7,250 shares made by Raymond J. Bartoszek , and a net purchase of 4,397 shares made by Craig W. Philips .

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,113 shares of Kineta Inc (KA) were sold and 50,250 shares were bought by its insiders, resulting in a net purchase of 44,137 shares.

Kineta Inc (KA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kineta Inc Insider Transactions

No Available Data

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Peter J Barris is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , EVP PHARM SCI & MFG Stapleton Raymond D Jr , and 10 percent owner Paul Edward Walker .

Genocea Biosciences Inc (GGNNQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genocea Biosciences Inc Insider Transactions

No Available Data

What does Revolution Acceleration Acquisition Corp do?

Who are the key executives at Revolution Acceleration Acquisition Corp?

Peter J Barris is the director of Revolution Acceleration Acquisition Corp. Other key executives at Revolution Acceleration Acquisition Corp include 10 percent owner Softbank Group Corp , director & Chief Executive Officer Thomas Anderson Wagner , and See Remarks Steven Jay Johnson .

Revolution Acceleration Acquisition Corp (RAACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Revolution Acceleration Acquisition Corp (RAACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Acceleration Acquisition Corp (RAACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Acceleration Acquisition Corp (RAACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Acceleration Acquisition Corp Insider Transactions

No Available Data

Peter J Barris Mailing Address

Above is the net worth, insider trading, and ownership report for Peter J Barris. You might contact Peter J Barris via mailing address: 1119 St Paul Street, Baltimore Md 21202.

Discussions on Peter J Barris

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.